General · 19 August 2026

Experimental mRNA drug stops skin cancer returning after surgery

Drugmakers Merck and Moderna announced on Wednesday that their personalised mRNA vaccine, intismeran, prevented melanoma from coming back or spreading. The experimental drug was given to over 1,000 patients who had surgery to remove their cancer, combined with another drug called Keytruda. Intismeran is a potentially significant step for people with melanoma, the deadliest form of skin cancer.

✓ Verified against the source · 60 words · 40 sec

Get the app

More briefs

GeneralIsrael invites tenders for 1,200 West Bank settlement homes GeneralHMRC sent 81,000 crypto tax warning letters in past year GeneralTarget gets nearly $1 billion in US tariff refunds GeneralLib Dems urge PM Burnham to join EU migration pact GeneralUkrainian man arrested in Croatia over alleged 2022 Nord Stream pipeline sabotage GeneralSeven died in Kenya helicopter crash, including Ecuador's intelligence chief and five Americans Browse all stories →